Formulation Note 001
01Why we reformulated a serum that already worked.
The actives weren't the problem. The finish was.
In development
The Journal
Skin, science and what comes after.
An editorial record of what we're learning as we build Sky Glow — from skin and ingredients to formulation decisions and the realities products are actually designed around. Published as the work is completed, not written in advance.
Ingredient Study 001
02PDRN, plainly
What 0.20% actually means, what topical evidence exists, what it does not prove, and why we included it.
In development
Formulation Note 002
03Why 5 / 3 / 2?
The reasoning behind 5% Niacinamide, 3% Tranexamic Acid, and 2% N-Acetyl Glucosamine.
In development
Skin, Explained 001
04Do screens actually affect your skin?
What the evidence supports, what gets exaggerated, and what may really be happening during long screen-heavy days.
In development
Rituals for Real Life 001
05The routine for when there is no routine.
A practical approach for long days, travel, heat, sweat, dry air, and changing schedules.
In development
Editorial structure
Evidence, with its limits intact.
- 01
What we know
- 02
What the evidence suggests
- 03
What it doesn't tell us
- 04
Why we used it
- 05
Sources
Dates, reading times, authorship, expert review, and sources will appear when each article is complete.
Future study
Glycation, without the fear-mongering.
What happens when sugars interact with proteins in skin, what researchers actually know about visible aging, and why ingredients like carnosine are being studied.